Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

Rhea-AI Summary

Eton Pharmaceuticals (Nasdaq: ETON), a pharmaceutical company focused on rare disease treatments, has scheduled its third quarter 2024 financial results announcement for Tuesday, November 12, 2024. Management will host a conference call and audio webcast at 4:30 p.m. ET to discuss the results. The company will take live questions during the call and answer emailed investor questions sent to investorrelations@etonpharma.com. The webcast will be accessible through Eton's investor relations website and will remain available for 30 days after the event.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DEER PARK, Ill., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (“Eton” or the "Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report third quarter 2024 financial results on Tuesday, November 12, 2024. Management will host a conference call and live audio webcast to discuss the results at 4:30 p.m. ET (3:30 p.m. CT).

Dial in (Audio Only)		Toll-free: 888-596-4144
		Non-toll free: 646-968-2525
		Access Code: 1144771
Webcast:		Click Here

In addition to taking live questions from participants on the conference call, management will be answering emailed questions from investors. Investors can email questions to: investorrelations@etonpharma.com.

The live webcast can also be accessed on the Investors section of Eton’s website at https://ir.etonpharma.com/. An archived webcast will be available on Eton’s website approximately two hours after the completion of the event and for 30 days thereafter.

About Eton Pharmaceuticals

Eton is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company currently has five commercial rare disease products: ALKINDI SPRINKLE®, PKU GOLIKE®, Carglumic Acid, Betaine Anhydrous, and Nitisinone. The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO® hydrocortisone autoinjector. For more information, please visit our website at www.etonpharma.com.

Investor Relations:

Lisa M. Wilson
In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com

Source: Eton Pharmaceuticals, Inc.

FAQ

When will Eton Pharmaceuticals (ETON) report Q3 2024 earnings?

Eton Pharmaceuticals will report its third quarter 2024 financial results on Tuesday, November 12, 2024.

What time is Eton Pharmaceuticals (ETON) Q3 2024 earnings call?

The earnings conference call and webcast will take place at 4:30 p.m. ET (3:30 p.m. CT) on November 12, 2024.

How can investors participate in Eton Pharmaceuticals (ETON) Q3 2024 earnings call?

Investors can join via phone (toll-free: 888-596-4144 or non-toll free: 646-968-2525, access code: 1144771) or watch the webcast on Eton's investor relations website. They can also submit questions via email to investorrelations@etonpharma.com.